Allianz Asset Management
COLL icon

Allianz Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Allianz Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,700
Closed -$409K – 2056
2025
Q1 		$409K Sell
13,700
-7,600
-36% -$232K ﹤0.01% 1943
2024
Q4 		$610K Buy
21,300
+14,400
+209% +$476K ﹤0.01% 1794
2024
Q3 		$267K Buy
+6,900
New +$246K ﹤0.01% 2017
2021
Q4 		– Sell
-14,521
Closed -$287K – 2566
2021
Q3 		$287K Buy
14,521
+239
+2% +$5.17K ﹤0.01% 2423
2021
Q2 		$337K Buy
+14,282
New +$330K ﹤0.01% 2221
2020
Q2 		– Sell
-68,347
Closed -$1.12M – 2408
2020
Q1 		$1.12M Buy
68,347
+15,384
+29% +$318K ﹤0.01% 1753
2019
Q4 		$1.09M Buy
+52,963
New +$883K ﹤0.01% 2147

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management's COLL Position: Q2 2025 in Review

Allianz Asset Management sold out of Collegium Pharmaceutical (COLL) in Q2 2025, closing a stake of 13,700 shares — an estimated $409K sold.

Allianz Asset Management first reported a position in COLL in Q4 2019 and held it in 7 quarters. The position peaked at $1.12M in Q1 2020. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

  • Allianz Asset Management reported no remaining Collegium Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Allianz Asset Management sold 13,700 Collegium Pharmaceutical shares in Q2 2025, an estimated $409K.
  • Allianz Asset Management first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 7 quarters.
  • Allianz Asset Management's Collegium Pharmaceutical position peaked at $1.12M in Q1 2020.
  • 223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.